Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone actually able to scoop up those 2's?
Premarket bid will be a lot higher at 9:30. Plus a lot of people have been sitting on the sidelines because of what happened 3 months ago. I'm sure there will be a lot of buying power early this morning
Because it goes down for two weeks after a huge climb and people start freaking out and saying how management sucks and so on.
If you can't even wait two weeks for this to start moving north again then you shouldn't be trading.
Yeah unfortunately my order at 13.5 didn't get filled
How is the chart looking bad? The way I see it, 50-day is supporting this baby until the next spike up.
You got some 9's? I got 500k at 0.001 and trying to get a bunch more at 9's... Am I the only one drooling here?
as of 8:55am bid 0.29 ask 0.30
Bad market day (week) across the board. Once the market picks up, this should go back up as well. Just pray to god that support level 0.002 does not get broken, otherwise we could be in trouble. 50-day going to break pass the 200-day soon so we should be ok if we hold 2's.
Yeah it's been a pretty bad week... Unfotunately I'm out of funds to avg down EVEN MORE.
That's good. Based on 9 months of investing, I have no clue what I'm doing.
I'll bet you my 3000000 shares at 0.001 They're available if you want.
who sold me their shares at 0.0008... lol I can't believe my order got filled
Normally I would agree with you, but even profit takers know there is a lot more profit to be taken than at 0.036... this is going up beyond 0.04 today and even higher tomorrow. I'll be taking my profit either tomorrow or Wednesday.
I smell green!!!!
I'm out for now, up 1.2k for the day. Will get back in if it drops again. GLTA
Also from Canada and I'm with CIBC Investor Edge. They didn't even give me a timeline as to when I will be receiving my shares. Just as pathetic as TD I guess.
And how do we go about getting these shares? Through our broker?
I did not catch that. Where does it say that HTDS shareholders receive 1 CVIT share for every 100 shared of HTDS?
New News: Hard To Treat Diseases (HTDS.PK) - 46,000 India Doses of Hepatitis A
SHENZHEN, China, Aug. 28 /PRNewswire-FirstCall/ - Hard to Treat Diseases (the "Company") (HTDS.PK) www.htdsmedical.com is pleased to announce that at the beginning of August, 2009, Mellow Hope transported another 46,000 doses of Hepatitis A vaccine to India. This is the third batch of this year. After the launch of Hepatitis A vaccine in India at the end of 2005, the market share keeps growing steadily for HTDS and the product is well accepted by local people.
Further updates to follow.
Safe Harbor Statement:
Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com; For any corporate matters, please contact corporate@htdsmedical.com, www.htdsmedical.com
SOURCE Hard to Treat Diseases
Link: http://www.sys-con.com/node/1086222
True longs don't get impatient. Did you really think they would start producing right away? Patience... Rome was not built in a day.
Anybody have Level 2 Quotes and how it suddenly dropped to 0.012?
Post Unavailable
Additional Information
Sucks for the world... good for HTDS.
Obviously I don't know what MM knows or I would be one of them. But by looking at the PPS, why such a huge tumble and then such a large recovery within one day... before the weekend? Because it has price manipulation all over it. Get people to panic and take whatever little profits they had left, then buy their cheap shares in expectation that HTDS will have good news next week (if not next week the week after that or the week after that... doesn't really matter exactly when, but good news is sure to come and will bring the pps up with it.
ok thanks
Apparently this was posted on Ihub... I must've missed it. Any comments?
http://www.hilbroyadvisory.com/pdfs/OTCPK_HTDS_DETAILED.pdf
password: research
Wasn't me who said 5 cents. I doubt the person who said 5 cents actually made any calculations (not that you can really calculate PINKS anyway). Probably just wishful thinking and their exit point.
It's the MM's buying all the shares that people sold due to panic. IMO
I think it's more manipulation. MM's know news is coming out next week so they brought the price down as much as they could getting weak people to sell their shares and making sure it didn't hit 0.05 since most people wanted to get back at that price.
Go longs!
I don't think Scott is worried about the share price right now. 6 cents or 12 cents... it won't matter to him once SRSR actually starts producing. Do you actually think Scott is worried about the daytraders?
it's at the bottom but here it is again.
http://ca.sys-con.com/node/1077985
Found it through google finance.
Hard To Treat Diseases (HTDS.PK) Stem Cell Graft Survival
By: PR Newswire
Aug. 20, 2009 08:39 AM
BELGRADE, Serbia, Aug. 20 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) www.htdsmedical.com Slavica Bio Chem www.slavicabiochem.com Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats. One of the goals of this project is to examine the potential role of Ribavirin in promoting survival of the stem cells transplanted after brain injury. This report with images will be posted on http://www.pinksheets.com/pink/quote/quote.jsp?symbol=htds shortly
The results of a pilot study in this project were presented at the Human Pluripotent Stem Cells symposium: interrogating disease and development, organized by Dr Stephen Sullivan and Abcam, Dublin, Ireland, April 22 - 24, 2009.
Neural stem cells (SC) are a promising therapeutic tool in CNS disease and injuries. However, there are a number of obstacles which have to be overcome in order to achieve a therapeutically beneficial outcome. These include the problem of inducing differentiation of multipotent grafted SCs into desired cell type, rejection of grafted SCs by the recipient's immune system and glial scar formation following the injury, which can present both physical and chemical barrier to SC migration and differentiation.
In our study, we detected that daily injection of Ribavirin for 5 and 10 days considerably decreased the degree of reactive astrogliosis after traumatic brain injury in adult rats. Decrease of reactive astrogliosis leads to downregulation of glial scar formation.
However, the beneficial effects that astroglial cells can exert on recovery after injury should not be neglected. Our group continues to test different duration times and timing of Ribavirin treatment, which we believe to be crucial in balancing the positive and negative effects that astrogliosis may have.
The results were reported in the Poster presentation session by Dr. Ivana Gadjanski, research scientist in the IBISS group. Our results drew significant consideration from the attending scientists.
URL for the Human Pluripotent Stem Cells symposium website: http://www.abcam.com/index.html?pageconfig=resource rid=11610 utm_campaign=Event.ESCIE utm_source=Abcam.Events utm_medium=Email utm_term=12494-Dublinemail intGoUser=3166517
In other company events: As previously announced the set up of a new, redesigned website for the subsidiary Slavica Biochem (http://www.slavicabiochem.com/) has been completed and the web site launched. The new website presents updated information material on the research topics of the Slavica Biochem medical team from Belgrade, Serbia. The website is made in a very user-friendly format providing ample general information on the Multiple Sclerosis (MS) and Traumatic Brain Injury (TBI), as well as specific details on the methodology and results of the Slavica medical team. Patients and potential shareholders can also find, listed in a submenu on the Slavica biochem website, a number of selected links to other specialized websites dealing with MS and TBI.
The company is also in the process of redesigning and launching its HTDS website shortly as well www.htdsmedical.com. The company intends to provide further updates on a timely and ongoing basis.
Safe Harbor Statement:
Information in this filing may contain statements about future expectations, plans, prospects or performance of Hard to Treat Diseases, Inc. that constitute forward-looking statements for purposes of the safe harbor Provision's under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. HTDS Corporation cautions you that any forward-looking information provided by or on behalf of Hard to Treat Diseases, Inc. is not a guarantee of future performance. None of the information in this filing constitutes or is intended as an offer to sell securities or investment advice of any kind. Hard to Treat Diseases, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond Hard to Treat Diseases, Inc.'s control. In addition to those discussed in Hard to Treat Diseases, Inc.'s press releases, public filings, and statements by Hard to Treat Diseases, Inc.'s management, including, but not limited to, Hard to Treat Diseases, Inc.'s estimate of the sufficiency of its existing capital resources, Hard to Treat Diseases, Inc.'s ability to raise additional capital to fund future operations, HTDS Corporation's ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match Hard to Treat Diseases, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. Hard to Treat Diseases, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
CONTACT: For medical and scientific dialogue inquiry only, please contact medicalinfo@htdsmedical.com; For any corporate matters, please contact corporate@htdsmedical.com, www.htdsmedical.com
SOURCE Hard to Treat Diseases
Published Aug. 20, 2009— Reads 209
Copyright © 2009 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
http://ca.sys-con.com/node/1077985
If everyone is uninterested, that's a good thing... Imagine when everyone will be interested... this will blow through the roof, way past the 0.20 mark.
Not dumb money but long money... won't matter if it's 0.09, 0.08 or 0.06... in the long run, SRSR will start producing and all the longs will be rich. Mining doesn't happen in a day.
For those longs, on days like this, just repeat in your head NCPC. An agreement with NCPC brought this stock up, and will make it go higher in the long run.
Do we really expect good news from HTDS every second day? That's unrealistic.
alright gap filled, let's roll
and there's 2
Let's fill that gap and head for deuces!